A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Sublingual/Oral Immunotherapy for the Treatment of Peanut Allergy

NCT01084174 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Peanut Hypersensitivity
Food Hypersensitivity
Immediate Hypersensitivity

Interventions

DRUG: Peanut powder
DRUG: Peanut extract
DRUG: Placebo extract
DRUG: Placebo powder

Sponsor

Johns Hopkins University